These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36017221)

  • 1. Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults.
    Shi S; Jiang Y; Chen W; Chen K; Liao Y; Huang K
    Front Nutr; 2022; 9():897774. PubMed ID: 36017221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between serum creatinine/cystatin C ratio and mortality in hypertensive patients.
    Liao L; Shi S; Ding B; Zhang R; Tu J; Zhao Y; Guo Q; Liao Y
    Nutr Metab Cardiovasc Dis; 2024 Feb; 34(2):369-376. PubMed ID: 37949717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the serum creatinine/cystatin C ratio in patients with chronic obstructive pulmonary disease.
    Kawasaki Y; Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T; Ishizaki T; Toga H; Mizuno S
    Respir Investig; 2024 Jan; 62(1):143-149. PubMed ID: 38134662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer.
    Sun J; Yang H; Cai W; Zheng J; Shen N; Yang X; Pan B; Zhang W; Chen X; Shen X
    BMC Gastroenterol; 2022 Jan; 22(1):26. PubMed ID: 35045814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the serum creatinine and cystatin C ratio for prediction of sarcopenia and prognosis in biliary tract cancer.
    Fukushima R; Harimoto N; Okuyama T; Seki T; Hoshino K; Hagiwara K; Kawai S; Ishii N; Tsukagoshi M; Igarashi T; Araki K; Shirabe K
    Int J Clin Oncol; 2024 Jul; 29(7):1002-1011. PubMed ID: 38683456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours.
    Ding P; Guo H; Sun C; Chen S; Yang P; Tian Y; Lowe S; Zhao Q
    Front Nutr; 2022; 9():963265. PubMed ID: 36118766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease.
    Hirai K; Tanaka A; Homma T; Goto Y; Akimoto K; Uno T; Yoshitaka U; Miyata Y; Inoue H; Ohta S; Suzuki S; Sagara H
    Clin Nutr; 2021 Mar; 40(3):1274-1280. PubMed ID: 32863062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic performance of Cr/CysC for sarcopenia and its predictive value on clinical outcomes in hospitalized older patients: a prospective cohort study.
    Tu X; Lin T; Huang L; Tang T; Xie D; Gao L; Jiang T; Yue J
    Eur Geriatr Med; 2024 Apr; 15(2):579-588. PubMed ID: 38393457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatinine/(cystatin C × body weight) ratio is associated with skeletal muscle mass index.
    Nishida K; Hashimoto Y; Kaji A; Okamura T; Sakai R; Kitagawa N; Osaka T; Hamaguchi M; Fukui M
    Endocr J; 2020 Jul; 67(7):733-740. PubMed ID: 32213726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel equations incorporating the sarcopenia index based on serum creatinine and cystatin C to predict appendicular skeletal muscle mass in patients with nondialysis CKD.
    Hsu BG; Wang CH; Lai YH; Kuo CH; Lin YL
    Clin Nutr; 2024 Mar; 43(3):765-772. PubMed ID: 38335801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis.
    Fujita K; Ohkubo H; Nakano A; Takeda N; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Maeno K; Ito Y; Oguri T; Ozawa Y; Murase T; Niimi A
    BMC Pulm Med; 2022 May; 22(1):203. PubMed ID: 35606777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical muscle mass-related biomarkers that predict mortality in older patients with community-acquired pneumonia.
    Huang S; Guo Y; Chen L; Wang Y; Chen X
    BMC Geriatr; 2022 Nov; 22(1):880. PubMed ID: 36402966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association between Serum Creatinine/Cystatin C Ratio and Cardiovascular Morbidity and Mortality: Insights from NHANES.
    Shi J; Wu Y; Zhu S; Xie Y; Xiang M
    Rev Cardiovasc Med; 2023 Sep; 24(9):275. PubMed ID: 39076382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease.
    Lin YL; Chen SY; Lai YH; Wang CH; Kuo CH; Liou HH; Hsu BG
    Clin Nutr; 2020 Aug; 39(8):2435-2441. PubMed ID: 31732290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer.
    Tsukagoshi M; Watanabe A; Araki K; Ishii N; Hagiwara K; Hoshino K; Muranushi R; Harimoto N; Takizawa M; Shirabe K
    Ann Gastroenterol Surg; 2023 Sep; 7(5):784-792. PubMed ID: 37663967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A baseline sarcopenia index based on creatinine/cystatin C for the prediction of stroke recurrence and mortality in older survivors of first ischemic strokes.
    Hou L; Chen X; Zhu C
    Front Public Health; 2023; 11():1049738. PubMed ID: 37841730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Huang D; Xie C; Sun C; Chen M; Li L; Yi H; Liao J; Zhao X; Shen X; He D; Li D; Wu D
    Int J Chron Obstruct Pulmon Dis; 2022; 17():781-789. PubMed ID: 35422619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic test accuracy of serum creatinine and cystatin C-based index for sarcopenia: a systematic review and meta-analysis.
    Lin T; Jiang T; Huang X; Xu P; Liang R; Song Q; Tu X; Zhao Y; Huang L; Yue J; Wu C
    Age Ageing; 2024 Jan; 53(1):. PubMed ID: 38251741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease.
    Hyun YY; Lee KB; Kim H; Kim Y; Chung W; Park HC; Han SH; Oh YK; Park SK; Oh KH
    Front Nutr; 2022; 9():996674. PubMed ID: 36225865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of Muscle Mass Using Creatinine/Cystatin C Ratio in Japanese Community-Dwelling Older People.
    Kusunoki H; Tabara Y; Tsuji S; Wada Y; Tamaki K; Nagai K; Itoh M; Sano K; Amano M; Maeda H; Sugita H; Hasegawa Y; Kishimoto H; Shimomura S; Igase M; Shinmura K
    J Am Med Dir Assoc; 2022 May; 23(5):902.e21-902.e31. PubMed ID: 34437868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.